FOUSE JACQUALYN A 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jun 24, 2025
Insider Transaction Report
Form 4
FOUSE JACQUALYN A
Director
Transactions
- Award
Common Stock
2025-06-20+203→ 1,097 total - Award
Stock Option (Right to Buy)
2025-06-20+366→ 366 totalExercise: $285.73Exp: 2035-06-20→ Common Stock (366 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided the Reporting Person continues in service with the Issuer on such date.
- [F2]The option vests as to 100% of underlying shares on the date of the Issuer's annual meeting of stockholders to be held in 2026, provided that the Reporting Person continues to serve as a director of the Issuer until such date.